Zheng Q - Search Results

1

Corrigendum: Effective management of atherosclerosis progress and hyperlipidemia with nattokinase: A clinical study with 1,062 participants.

Chen H, Chen J, Zhang F, Li Y, Wang R, Zheng Q, Zhang X, Zeng J, Xu F, Lin Y. Chen H, et al. Among authors: zheng q. Front Cardiovasc Med. 2022 Dec 5;9:1076420. doi: 10.3389/fcvm.2022.1076420. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 36545015 Free PMC article.

2

[Protein tyrosine kinase activation in the repair of rat gastric mucosa after damage].

Zeng J, Zheng Q, Zhang W. Zeng J, et al. Among authors: zheng q. Zhonghua Yi Xue Za Zhi. 1999 Dec;79(12):934-7. Zhonghua Yi Xue Za Zhi. 1999. PMID: 11715511 Chinese.

3

Effective management of atherosclerosis progress and hyperlipidemia with nattokinase: A clinical study with 1,062 participants.

Chen H, Chen J, Zhang F, Li Y, Wang R, Zheng Q, Zhang X, Zeng J, Xu F, Lin Y. Chen H, et al. Among authors: zheng q. Front Cardiovasc Med. 2022 Aug 22;9:964977. doi: 10.3389/fcvm.2022.964977. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 36072877 Free PMC article.

4

[Advances of immunotherapy-related biomarker in esophageal carcinoma].

Zhang RX, Kang XZ, Zheng QF, Wang Z, Chen XK, Li Y, Qin JJ, Li Y. Zhang RX, et al. Among authors: zheng qf. Zhonghua Wei Chang Wai Ke Za Zhi. 2023 Apr 25;26(4):396-400. doi: 10.3760/cma.j.cn441530-20221213-00522. Zhonghua Wei Chang Wai Ke Za Zhi. 2023. PMID: 37072320 Chinese.

5

L-carnitine attenuated hyperuricemia-associated left ventricular remodeling through ameliorating cardiomyocytic lipid deposition.

Yang Y, Lin C, Zheng Q, Zhang L, Li Y, Huang Q, Wu T, Zhao Z, Li L, Luo J, Jiang Y, Zhang Q, Wang X, Xia C, Pang J. Yang Y, et al. Among authors: zheng q. Front Pharmacol. 2023 Jan 31;14:1016633. doi: 10.3389/fphar.2023.1016633. eCollection 2023. Front Pharmacol. 2023. PMID: 36817129 Free PMC article.

6

Correction to: A Cost‑effectiveness Analysis of iGlarLixi Versus IDegAsp and Appropriate Price Exploration of iGlarLixi for Type 2 Diabetes Mellitus Patients in China.

Jiang Y, Liu R, Xuan J, Lin S, Zheng Q, Zhang Q, Pang J. Jiang Y, et al. Among authors: zheng q. Clin Drug Investig. 2023 May;43(5):381. doi: 10.1007/s40261-023-01269-4. Clin Drug Investig. 2023. PMID: 37115344 No abstract available.

7

A Cost-effectiveness Analysis of iGlarLixi Versus IDegAsp and Appropriate Price Exploration of iGlarLixi for Type 2 Diabetes Mellitus Patients in China.

Jiang Y, Liu R, Xuan J, Lin S, Zheng Q, Pang J. Jiang Y, et al. Among authors: zheng q. Clin Drug Investig. 2023 Apr;43(4):251-263. doi: 10.1007/s40261-023-01255-w. Epub 2023 Mar 21. Clin Drug Investig. 2023. PMID: 36943659

8

Assessment of the influence on left ventricle by potassium oxonate and hypoxanthine-induced chronic hyperuricemia.

Lin C, Zheng Q, Li Y, Wu T, Luo J, Jiang Y, Huang Q, Yan C, Zhang L, Zhang W, Liao H, Yang Y, Pang J. Lin C, et al. Among authors: zheng q. Exp Biol Med (Maywood). 2023 Jan;248(2):165-174. doi: 10.1177/15353702221120113. Epub 2022 Sep 12. Exp Biol Med (Maywood). 2023. PMID: 36112877 Free PMC article.

9

New Triterpenoids from the Leaves of Heritiera littoralis and Their Anti-Inflammatory Activity.

Ren C, Liang X, Pi R, Xin J, Yang B, Zheng Q, Li Y, Li J, Zhang Y. Ren C, et al. Among authors: zheng q. Molecules. 2024 Dec 31;30(1):131. doi: 10.3390/molecules30010131. Molecules. 2024. PMID: 39795187

10

Associations between surrogate insulin resistance indexes and osteoarthritis: NHANES 2003-2016.

Lan Y, Zheng Q, Li M, Chen J, Huang D, Lin L. Lan Y, et al. Among authors: zheng q. Sci Rep. 2025 Jan 10;15(1):1578. doi: 10.1038/s41598-024-84317-z. Sci Rep. 2025. PMID: 39794440

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8,648 results

Search Page

Filters